2011
DOI: 10.4103/0976-7800.92537
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and related risk factors of osteoporosis in peri- and postmenopausal Indian women

Abstract: Aim:We undertook this study involving 200 peri- and postmenopausal women to determine the prevalence of osteoporosis, and in turn increase the awareness, education, prevention, and treatment of osteoporosis.Setting and Design:Postgraduate Institute of Medical Education and Research, UT Chandigarh, India, and a clinical study.Materials and Methods:A detailed medical, obstetrical, menstrual, and drug history was recorded in a proforma designated for the study. Height and weight was measured, weight-bearing exerc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
23
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 34 publications
(24 citation statements)
references
References 14 publications
1
23
0
Order By: Relevance
“…The major predictor of greater hip fracture risk is low bone mineral density (BMD) in the femoral neck; yet, studies have not found strong associations between low SES and low femoral neck BMD [9,10,11,12,13]. Of the various indicators of adult SES, education level more than income, occupation, or wealth, has shown consistent associations with BMD [14,15,16,17,18].…”
Section: Introductionmentioning
confidence: 99%
“…The major predictor of greater hip fracture risk is low bone mineral density (BMD) in the femoral neck; yet, studies have not found strong associations between low SES and low femoral neck BMD [9,10,11,12,13]. Of the various indicators of adult SES, education level more than income, occupation, or wealth, has shown consistent associations with BMD [14,15,16,17,18].…”
Section: Introductionmentioning
confidence: 99%
“…[910] A previous study[11] attempted to determine the prevalence of osteoporosis in Indian women and reported that 106 of the studied 200 patients had low BMD (osteopenia and osteoporosis). The overall prevalence of osteoporosis has been reported to be higher in the Asian populations than their western counterparts.…”
Section: Discussionmentioning
confidence: 99%
“…[12] This may be due to the racial factors and also to the fact that most of the Asian countries are less developed ones with the problems of poor nutritional status, frequent childbirth, poor socioeconomic status, poor educational levels among others contributing to low BMD and hence osteoporosis. [11] While detailed clinical practice guidelines on postmenopausal guidelines have been published by the Indian menopause society,[13] prevention of complications of postmenopausal osteoporosis cannot be done without the participation of the target population and hence an assessment of awareness of osteoporosis among postmenopausal women appears to be the logical first step in this process. A literature search failed to provide us with any study assessing the awareness among Indian population, and hence, we attempted to study the same in population in and around Chandigarh, India using a representative sample.…”
Section: Discussionmentioning
confidence: 99%
“…The high prevalence of osteoporosis or osteopenia in India, estimated at 50 million in 2013,[ 6 ] may be the result of low dietary intake of calcium, calories, protein, lack of exercise,[ 2 7 ] and vitamin D insufficiency (defined in the study as serum 25-hydroxyvitamin D [25(OH)D] levels 10-20 ng/mL) and deficiency (levels <10 ng/mL). [ 8 ] In Jammu (N = 158), 20% of women aged 25 to 65 years had osteoporosis (T-score <-2.5) and 37% had osteopenia (T-score ≤-1 and ≥-2.5), both of which were found to increase in incidence with age and menopause.…”
Section: Discussionmentioning
confidence: 99%
“…Rates of decreased BMD in Indian women range from 20% to 50% depending on the geographic region within India. [ 2 3 4 ] Because osteoporosis is a major health issue in India, this study ( ClinicalTrials.gov identifier: NCT01495000; study number: DPH 114161) was designed to compare the efficacy and safety of a single dose of denosumab 60 mg versus placebo in Indian postmenopausal women with osteoporosis.…”
Section: Introductionmentioning
confidence: 99%